Ribbon Acquisition Corp.
Company Information
Industry
Blank Checks
SIC Code
6770
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
Cayman Islands
Business Address
CENTRAL PARK TWR LATOUR SHINJUKU RM 3001, TOKYO, M0, 160-0023
Mailing Address
CENTRAL PARK TWR LATOUR SHINJUKU RM 3001, TOKYO, M0, 160-0023
Phone
819085083462
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
$690K
Net Income
$52.00M
Total Assets
$2.61M
Total Liabilities
$15K
Stockholders' Equity
$11K
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 31, 2026 | View on SEC |
| 8-K Current report of material events | March 27, 2026 | View on SEC |
| 8-K Current report of material events | March 16, 2026 | View on SEC |
| 8-K Current report of material events | March 16, 2026 | View on SEC |
| 8-K Current report of material events | March 12, 2026 | View on SEC |
| 8-K Current report of material events | March 12, 2026 | View on SEC |
| 8-K Current report of material events | March 9, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | February 23, 2026 | View on SEC |
| 8-K Current report of material events | February 18, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 17, 2026 | View on SEC |
Annual Reports
10-K
March 31, 2026
- Ribbon Acquisition Corp. has entered a definitive merger agreement with DRC Medicine Inc.
- The merger will transition Ribbon from a SPAC shell company into a public medical technology firm.
Related Companies
Companies in the same industry (SIC: 6770)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.